Although gastrointestinal adverse effects are well characterised, the pulmonary safety profile of GLP-1 RAs remains incompletely defined, representing an important evidence gap given the scale of global prescribing
Personalized Glutathione Protocols and Precision Medicine The future of injectable glutathione therapy likely involves increasingly personalized approaches that account for individual genetic variations affecting glutathione metabolism, baseline glutathione status assessed through specialized testing, specific oxidative stress burdens based on environmental exposures and lifestyle factors, health goals and priorities that vary among individuals, and response patterns to glutathione therapy including dosing requirements and optimal administration routes
They may order other blood tests and urine tests to check for unwanted effects
Granfeldt, Y., Drews, A., & Bjorck, I
In the brain, GLP-1 receptor activation affects areas that regulate appetite and satiety, leading to reduced hunger and increased feelings of fullness
This will likely require FDA approval of suzetrigine / VX-548 (potentially by Q1 2025) before an ethical study design is possible, to ensure long term access to suzetrigine for successfully transitioned patients
